本页面由Tiger Trade Technology Pte. Ltd.提供服务

X4制药

4.05
+0.01000.25%
成交量:29.92万
成交额:121.11万
市值:4.02亿
市盈率:-3.27
高:4.10
开:4.03
低:3.94
收:4.04
52周最高:4.83
52周最低:2.80
股本:9,914.67万
流通股本:6,235.43万
量比:0.41
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-1.2404
每股收益(LYR):-1.8726
净资产收益率:-113.08%
总资产收益率:-28.15%
市净率:2.58
市盈率(LYR):-2.16

数据加载中...

2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/01

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/05/13

SEC问询函

Form CORRESP - Correspondence
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/27

重要事件披露

Form 8-K - Current report
2025/09/17

重要事件披露

Form 8-K - Current report
2025/09/15

SEC问询函

Form CORRESP - Correspondence